A new antiprostatic agent for treatment of prostatic carcinoma
Irwin, R.J.; Prout, G.R.
Surgical Forum 24: 536-537
1973
ISSN/ISBN: 0071-8041 PMID: 4806089 Document Number: 59413
Document emailed within 1 workday
Related Documents
Bogdanowicz, J.F.; Bentvelsen, F.M.; Oosterom, R.; Schroeder, F.H. 1991: Evaluation of prostate-specific antigen and prostatic acid phosphatase in untreated prostatic carcinoma and benign prostatic hyperplasia Scandinavian Journal of Urology and Nephrology. Supplementum 138: 97-103Kumamoto, Y.; Tsukamoto, T.; Umehara, T.; Harada, M.; Shimazaki, J.; Fuse, H.; Oshima, H.; Takeuchi, H.; Yoshida, O.; Okada, K. 1990: Clinical studies on endocrine therapy of prostatic carcinoma (3): Histopathological features of prostatic carcinoma and its prognosis Hinyokika Kiyo. Acta Urologica Japonica 36(3): 295-305
Sarfaty, G.A.; Alder, S.J.; McLean, R.G. 1984: A pilot study of flutamide. a new agent in the treatment of advanced prostatic cancer Medical Journal of Australia 140(4): 219-221
Weinberg, D.S.; Weidner, N. 1993: Concordance of DNA content between prostatic intraepithelial neoplasia and concomitant invasive carcinoma. Evidence that prostatic intraepithelial neoplasia is a precursor of invasive prostatic carcinoma Archives of Pathology and Laboratory Medicine 117(11): 1132-1137
Shimazaki, J.; Fuse, H.; Akimoto, S.; Sumiya, H.; Akakura, K.; Ichikawa, T. 1988: Prostatic carcinoma. I: Androgen dependency of prostatic carcinoma Gan to Kagaku Ryoho. Cancer and ChemoTherapy 15(4 Pt: 2-1): 909-916
Lohse, R.; Schubert, J. 1972: Treatment of advanced metastasizing prostatic carcinoma Das Deutsche Gesundheitswesen 27(26): 1238-1241
Mathé, G.; Schally, A.V.; Vo Van, M.L.; Duchier, J.; Misset, J.L.; Keiling, R. 1984: An analog of gonadoliberin in the treatment of prostatic carcinoma Presse Medicale 13(23): 1443-1445
Vachalovský, V.; Vomácka, V. 1988: Orimeten in the treatment of advanced prostatic carcinoma Rozhledy V Chirurgii: Mesicnik Ceskoslovenske Chirurgicke Spolecnosti 67(10): 666-670
Okumura, S.; Hasegawa, J.; Ohhara, M.; Kawamura, N.; Abe, H.; Yui, Y.; Kanamori, S.; Yoshida, K.; Nishimura, T.; Tomita, M. 1984: Treatment of advanced prostatic carcinoma with cis-diamminedichloroplatinum Hinyokika Kiyo. Acta Urologica Japonica 30(12): 1801-1807
Rafla, S.; Johnson, R. 1974: The treatment of advanced prostatic carcinoma with medroxyprogesterone Current Therapeutic Research 16(4): 261-267
Sáenz de Chirife, A.M.; Bassi, A.M.; Celeste, F.; Bergdolt, D. 1991: Specific prostatic antigen in prostatic carcinoma: its relationship with tumor differentiation and clinical course Archivos Espanoles de Urologia 44(4): 405-409
Strohmenger, P. 1980: Prostatic adenoma--prostatic carcinoma. Questions from general practice. II. Therapy Zfa. Zeitschrift für Allgemeinmedizin 56(28): 1793-1797
Pretlow, T.G.; Whitehurst, G.B.; Pretlow, T.P.; Hunt, R.S.; Jacobs, J.M.; McKenzie, D.R.; McDaniel, H.G.; Hall, L.M.; Bradley, E.L. 1982: Decrease in creatine kinase in human prostatic carcinoma compared to benign prostatic hyperplasia Cancer Research 42(11): 4842-4848
Morávek, P.; Sercl, M.; Heger, L. 1986: Computerized tomography in the diagnosis and treatment of prostatic carcinoma Rozhledy V Chirurgii: Mesicnik Ceskoslovenske Chirurgicke Spolecnosti 65(11): 768-774
Pavone-Macaluso, M. 1985: Which endocrine treatment is preferred today for prostatic carcinoma? La Ricerca in Clinica e in Laboratorio 15(Suppl 2): 87-94
Korczak, D.; Golomb, J.; Siegel, Y.; Lindner, A. 1988: Treatment of advanced prostatic carcinoma with LHRH analogue Harefuah 115(5-6): 109-111
Sack, H. 1973: Treatment of prostatic carcinoma from the clinical radiological viewpoint Rontgen-Blatter; Zeitschrift für Rontgen-Technik und Medizinisch-Wissenschaftliche Photographie 26(10): 427-430
Bologna, M.; Festuccia, C.; Vicentini, C.; Muzi, P.; Biordi, L.; De Nicola, G.; Ventura, T. 1991: Establishment and characterization of a human prostatic carcinoma cell strain obtained from exfoliated tumor cells after prostatic massage Tumori 77(1): 70-75
Abdalla, A.M.; Oliver, J.A. 1971: SV40 virus transformed prostatic carcinoma in the hamster. I. Comparisons of lactate dehydrogenase isoenzymes with human prostatic cancer Investigative Urology 8(4): 442-447
Hire, E.A.; Samson, M.K.; Fraile, R.J.; Baker, L.H. 1979: Use of VM-26 as a single agent in the treatment of renal carcinoma Cancer Clinical Trials 2(4): 293-295